Suramin, an active drug for prostate cancer: interim observations in a phase I trial.
Eisenberger MA, Reyno LM, Jodrell DI, Sinibaldi VJ, Tkaczuk KH, Sridhara R, Zuhowski EG, Lowitt MH, Jacobs SC, Egorin MJ.
J Natl Cancer Inst. 1993 Apr 21;85(8):611-21. Erratum in: J Natl Cancer Inst 1994 Apr 20;86(8):639-40. PMID: 8468719 [PubMed - indexed for MEDLINE]Related articles